Teva Pharmaceutical Indus (NYSE:TEVA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Teva Pharmaceutical Indus reported in-line EPS of $0.55 versus an estimate of $0.55.
Revenue was down $321.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 2.0% drop in the share price the next day.
Here's a look at Teva Pharmaceutical Indus's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.73 | 0.65 | 0.59 | 0.59 |
| EPS Actual | 0.77 | 0.59 | 0.59 | 0.63 |
| Revenue Estimate | 4.29B | 4.03B | 4.04B | 4.02B |
| Revenue Actual | 4.10B | 3.89B | 3.91B | 3.98B |
To track all earnings releases for Teva Pharmaceutical Indus visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
